QQQ   432.78 (+0.40%)
AAPL   169.94 (-1.59%)
MSFT   416.96 (+0.80%)
META   502.14 (+0.38%)
GOOGL   155.22 (+0.23%)
AMZN   184.07 (+0.25%)
TSLA   157.20 (-2.65%)
NVDA   878.92 (+2.20%)
AMD   164.10 (+2.36%)
NIO   3.85 (-1.03%)
BABA   69.99 (-0.89%)
T   16.08 (-0.99%)
F   12.19 (-0.33%)
MU   122.48 (+0.91%)
GE   156.90 (+2.08%)
CGC   6.78 (-2.87%)
DIS   114.08 (+1.00%)
AMC   2.78 (+12.55%)
PFE   25.79 (-0.46%)
PYPL   63.80 (+0.46%)
XOM   119.07 (-0.51%)
QQQ   432.78 (+0.40%)
AAPL   169.94 (-1.59%)
MSFT   416.96 (+0.80%)
META   502.14 (+0.38%)
GOOGL   155.22 (+0.23%)
AMZN   184.07 (+0.25%)
TSLA   157.20 (-2.65%)
NVDA   878.92 (+2.20%)
AMD   164.10 (+2.36%)
NIO   3.85 (-1.03%)
BABA   69.99 (-0.89%)
T   16.08 (-0.99%)
F   12.19 (-0.33%)
MU   122.48 (+0.91%)
GE   156.90 (+2.08%)
CGC   6.78 (-2.87%)
DIS   114.08 (+1.00%)
AMC   2.78 (+12.55%)
PFE   25.79 (-0.46%)
PYPL   63.80 (+0.46%)
XOM   119.07 (-0.51%)
QQQ   432.78 (+0.40%)
AAPL   169.94 (-1.59%)
MSFT   416.96 (+0.80%)
META   502.14 (+0.38%)
GOOGL   155.22 (+0.23%)
AMZN   184.07 (+0.25%)
TSLA   157.20 (-2.65%)
NVDA   878.92 (+2.20%)
AMD   164.10 (+2.36%)
NIO   3.85 (-1.03%)
BABA   69.99 (-0.89%)
T   16.08 (-0.99%)
F   12.19 (-0.33%)
MU   122.48 (+0.91%)
GE   156.90 (+2.08%)
CGC   6.78 (-2.87%)
DIS   114.08 (+1.00%)
AMC   2.78 (+12.55%)
PFE   25.79 (-0.46%)
PYPL   63.80 (+0.46%)
XOM   119.07 (-0.51%)
QQQ   432.78 (+0.40%)
AAPL   169.94 (-1.59%)
MSFT   416.96 (+0.80%)
META   502.14 (+0.38%)
GOOGL   155.22 (+0.23%)
AMZN   184.07 (+0.25%)
TSLA   157.20 (-2.65%)
NVDA   878.92 (+2.20%)
AMD   164.10 (+2.36%)
NIO   3.85 (-1.03%)
BABA   69.99 (-0.89%)
T   16.08 (-0.99%)
F   12.19 (-0.33%)
MU   122.48 (+0.91%)
GE   156.90 (+2.08%)
CGC   6.78 (-2.87%)
DIS   114.08 (+1.00%)
AMC   2.78 (+12.55%)
PFE   25.79 (-0.46%)
PYPL   63.80 (+0.46%)
XOM   119.07 (-0.51%)
Free Trial

Teva Pharmaceutical Industries (TEVA) Earnings Date, Estimates & Call Transcripts

→ Can't believe it's happening again (From Manward Press) (Ad)
Free TEVA Stock Alerts
$13.16
-0.07 (-0.53%)
(As of 03:27 PM ET)
Compare
Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media

Earnings Summary

Upcoming
Earnings Date
May. 8
Before Market Opens
Confirmed
Actual EPS
(Jan. 31)
$0.98 Beat By $0.25
Consensus EPS
(Jan. 31)
$0.73
Skip Charts & View Estimated and Actual Earnings Data
Earnings Per ShareRevenue

TEVA Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

TEVA Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Teva Pharmaceutical Industries Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateCompany Guidance
Q1 20241$0.48$0.48$0.48 
Q2 20241$0.56$0.56$0.56 
Q3 20241$0.51$0.51$0.51 
Q4 20241$0.66$0.66$0.66 
FY 20244$2.21$2.21$2.21 
Q1 20251$0.44$0.44$0.44 
Q2 20251$0.56$0.56$0.56 
Q3 20251$0.61$0.61$0.61 
Q4 20251$0.77$0.77$0.77 
FY 20254$2.38$2.38 $2.38

TEVA Earnings Date and Information

Teva Pharmaceutical Industries last posted its earnings data on January 31st, 2024. The reported $0.98 EPS for the quarter, topping analysts' consensus estimates of $0.73 by $0.25. The company earned $4.46 billion during the quarter, compared to the consensus estimate of $3.97 billion. Teva Pharmaceutical Industries has generated ($0.47) earnings per share over the last year (($0.47) diluted earnings per share). Earnings for Teva Pharmaceutical Industries are expected to grow by 10.09% in the coming year, from $2.28 to $2.51 per share. Teva Pharmaceutical Industries has confirmed that its next quarterly earnings report will be published on Wednesday, May 8th, 2024. Teva Pharmaceutical Industries will be holding an earnings conference call on Wednesday, May 8th at 8:00 AM Eastern. Interested parties can register for or listen to the call..

Teva Pharmaceutical Industries Earnings History by Quarter

Export to Excel
DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript
5/8/2024
Confirmed)		-------  
1/31/2024Q4 2023$0.73$0.98+$0.25$1.55$3.97 billion$4.46 billion
11/8/2023Q3 2023$0.57$0.60+$0.03$1.09$3.73 billion$3.90 billion    
8/2/2023Q2 2023$0.52$0.54+$0.02$1.85$3.69 billion$3.88 billion
5/10/2023Q1 2023$0.55$0.37($0.18)$0.92$3.60 billion$3.66 billion
2/8/2023Q4 2022$0.64$0.68+$0.04$2.46$3.90 billion$3.88 billion
11/3/2022Q3 2022$0.58$0.56($0.02)$1.07$3.86 billion$3.60 billion    
7/26/2022Q2 2022$0.55$0.64+$0.09$1.49$3.82 billion$3.79 billion
5/3/2022Q1 2022$0.53$0.53-$1.92$3.75 billion$3.66 billion    
2/9/2022Q4 2021$0.70$0.74+$0.04$1.62$4.28 billion$4.10 billion    
10/27/2021Q3 2021$0.65$0.59($0.06)$0.88$4.05 billion$3.89 billion    
7/28/2021Q2 2021$0.55$0.59+$0.04$0.95$4.03 billion$3.91 billion    
4/28/2021Q1 2021$0.55$0.63+$0.08$1.13$4.04 billion$3.98 billion  

Teva Pharmaceutical Industries Earnings - Frequently Asked Questions

When is Teva Pharmaceutical Industries's earnings date?

Teva Pharmaceutical Industries has confirmed that its next quarterly earnings data will be published on Wednesday, May 8th, 2024. Learn more on TEVA's earnings history.

Did Teva Pharmaceutical Industries beat their earnings estimates last quarter?

In the previous quarter, Teva Pharmaceutical Industries (NYSE:TEVA) reported $0.98 earnings per share (EPS) to beat the analysts' consensus estimate of $0.73 by $0.25. Learn more on analysts' earnings estimate vs. TEVA's actual earnings.

How much revenue does Teva Pharmaceutical Industries generate each year?

Teva Pharmaceutical Industries (NYSE:TEVA) has a recorded annual revenue of $15.85 billion.

How much profit does Teva Pharmaceutical Industries generate each year?

Teva Pharmaceutical Industries (NYSE:TEVA) has a recorded net income of -$559 million. TEVA has generated -$0.47 earnings per share over the last four quarters.

What is Teva Pharmaceutical Industries's price-to-earnings ratio?

Teva Pharmaceutical Industries (NYSE:TEVA) has a forward price-to-earnings ratio of 5.78. The price/earnings-to-growth ratio is 1.54.

What is Teva Pharmaceutical Industries's EPS forecast for next year?

Teva Pharmaceutical Industries's earnings are expected to grow from $2.28 per share to $2.51 per share in the next year, which is a 10.09% increase.


More Earnings Resources from MarketBeat

Related Companies:
Earnings Tools:
Earnings By Country:
Latest Articles:
This page (NYSE:TEVA) was last updated on 4/16/2024 by MarketBeat.com Staff

From Our Partners
Can't believe it's happening again
Manward Press
He Is Giving Away Bitcoin
Crypto Swap Profits
This Apple-like Innovator is Revolutionizing Healthcare
Wall Street Star
Healthcare Takes A Big Step Forward With The Help Of AI
The Bull Report
Your eBook: Mastering Earnings Announcements Trading
StockEarnings
The "Smart Money" Is Ready for May 1st Are You?
Stansberry Research
Options trading has suddenly become more reliable.
Eagle Publishing
Top 5 AI Stocks to Buy for 2024
Market Moving Trends